DAIVOBET 50mcg / 0.5mg / g ointment medication leaflet

D05AX52 calcipotriol + betamethasone • Dermatologicals | Antipsoriatics for topical use | Other antipsoriatics for topical use

Calcipotriol and betamethasone are used together for the treatment of plaque psoriasis, a chronic skin condition characterized by red patches covered with whitish scales. This combination reduces inflammation, itching, and slows down the excessive growth of skin cells.

Calcipotriol is a vitamin D analog that helps normalize the cell regeneration process, while betamethasone is a potent corticosteroid that reduces inflammation and suppresses local immune reactions.

The treatment is applied topically, usually in the form of an ointment or gel, and is intended for short-term use to avoid corticosteroid-related side effects. It is important to avoid application on the face, skin folds, or areas with thin skin.

Side effects may include local irritation, burning sensation, or itching. Long-term use can lead to skin thinning or other corticosteroid-related complications.

General data about DAIVOBET 50mcg / 0.5mg / g

Substance: calcipotriol + betamethasone

Date of last drug list: 10-04-2026

Commercial code: W56194001

Concentration: 50mcg / 0.5mg / g

Pharmaceutical form: ointment

Quantity: 1

Product type: original

Price: 41.59 RON

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

Manufacturer: LEO LABORATORIES LTD. - IRLANDA

Holder: LEO PHARMA A/S - DANEMARCA

Number: 4418/2012/01

Shelf life: 2 years-after packing for marketing; after the first opening-1 year

Pharmaceutical forms available for calcipotriol + betamethasone

Concentrations available for calcipotriol + betamethasone

0.5mg/g, 50mcg/0.5mg/g

Other substances similar to calcipotriol + betamethasone

Compensation lists for DAIVOBET 50mcg / 0.5mg / g LEO PHARMA

B - Sublist B with 50% discount from the reference price

Price

Copayment

Patient

41.59 RON

20.80 RON

20.80 RON